Sandip Pravin Patel

Also affiliated with National Foundation for Cancer Research, UC San Diego Health System, University of California San Diego, Novartis (China), San Diego Cardiac Center, Moores Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.803Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae009

Top 44%

0.418DataRank

Top 44%6 citations

Sandip Pravin Patel, Young Kwang Chae, Eliana Dietrich, Howard Streicher, Elad Sharon +2 more

Papers

Driven by 41 papers — median percentile 54. Top paper: “Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)”.

Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002990

N/A

4.8DataRank · unranked

160 citations

Megan Othus, Sandip Pravin Patel, Chris Ryan, Ashish Sangal, Benjamin Powers +15 more

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2182

N/A

3.8DataRank · unranked

125 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.1918986117

N/A

0.956DataRank · unranked

586 citations

Yuqi Kang, Lingling Wang, Sarah Huff, R. Tang, Hui Hui +6 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2824

N/A

0.656DataRank · unranked

22 citations

Randy F. Sweis, J. Randolph Hecht, Reva Schneider, Mark N. Stein, Talia Golan +7 more

Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

Nature Communications(2023)10.1038/s41467-023-38271-5

N/A

0.633DataRank · unranked

67 citations

Timothy J. Sears, Victoria H. Wu, Eva Pérez‐Guijarro, Hyo Kim, A. Castro +24 more

Robustness of cancer microbiome signals over a broad range of methodological variation

Oncogene(2024)10.1038/s41388-024-02974-w

N/A

0.628DataRank · unranked

65 citations

Daniel McDonald, Evguenia Kopylova, Caitlin Guccione, Qiyun Zhu, George I. Austin +16 more

Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

Scientific Reports(2021)10.1038/s41598-021-96467-5

N/A

0.590DataRank · unranked

50 citations

Ila M. Saunders, Isaac Cohen, Mengxing Li, Talar Moumedjian, Masara A. Issa +5 more

Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1073

N/A

0.524DataRank · unranked

32 citations

Megan Othus, Sandip Pravin Patel, Young Kwang Chae, Kathy D. Miller, Rashmi Chugh +8 more

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2293

N/A

0.505DataRank · unranked

28 citations

Megan Othus, Young Kwang Chae, Michael J. Dennis, Sarah Gordon, David G. Mutch +9 more

Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009074

N/A

0.503DataRank · unranked

12 citations

Megan Othus, Young Kwang Chae, Tridu R. Huynh, Benjamin Tan, Timothy M. Kuzel +9 more

SWOG 1609 cohort 48: anti–CTLA‐4 and anti–PD‐1 for advanced gallbladder cancer

Cancer(2024)10.1002/cncr.35243

N/A

0.496DataRank · unranked

15 citations

Elizabeth Guadarrama, Young Kwang Chae, Michael J. Dennis, Benjamin Powers, Chih‐Yi Liao +9 more

Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae009

Top 44%

0.418DataRank

Top 44%6 citations

Sandip Pravin Patel, Young Kwang Chae, Eliana Dietrich, Howard Streicher, Elad Sharon +2 more

First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae297

Top 47%

0.385DataRank

Top 47%8 citations

Sandip Pravin Patel, Young Kwang Chae, Eliana Dietrich, Howard Streicher, Elad Sharon +2 more

Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009128

N/A

0.380DataRank · unranked

9 citations

Megan Othus, Sandip Pravin Patel, Benjamin Powers, Chung-Tsen Hsueh, Rangaswamy Govindarajan +11 more

PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections

Science Translational Medicine(2024)10.1126/scitranslmed.adi6887

N/A

0.330DataRank · unranked

8 citations

Anghesom Ghebremedhin, Isaraphorn Pratumchai, Sally R. Robinson, Courtney B. Betts, Jingjing Hu +37 more

Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma

npj Precision Oncology(2025)10.1038/s41698-024-00798-1

N/A

0.303DataRank · unranked

5 citations

Eleanor Cano-Linson, Young Kwang Chae, Shiruyeh Schokrpur, Christopher D. Lao, Benjamin Powers +13 more

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011760

N/A

0.245DataRank · unranked

4 citations

Jillian Fisher, Young Kwang Chae, Luisa M. Solis Soto, Anup Kasi, Bhavana Konda +27 more

Linoleoyl-lysophosphatidylcholine suppresses immune-related adverse events due to immune checkpoint blockade

medRxiv(2024)10.1101/2024.08.07.24310974

N/A

0.208DataRank · unranked

3 citations

Priyanka Saminathan, Mir Henglin, Mingyue Liu, Namratha Nadig, Camille Fang +28 more

Evaluation of change in RECIST tumor size and survival in patients with rare cancers treated with checkpoint inhibitor therapy (SWOG S1609).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2504

N/A

0.104DataRank · unranked

1 citations

Sandip Pravin Patel, Young Kwang Chae, Eliana Dietrich, Howard Streicher, Elad Sharon +2 more

Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609)

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2900

N/A

0.104DataRank · unranked

1 citations

S Solomon, Sandip Pravin Patel, Zouina Sarfraz, Megan Othus, Young Kwang Chae +2 more

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359241293401

N/A

0.104DataRank · unranked

1 citations

Megan Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim +10 more

CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer

Frontiers in Immunology(2022)10.3389/fimmu.2022.842653

N/A

0DataRank · unranked

21 citations

Ahmad Alimadadi, Daniel J. Araujo, David J. Barry, Norma A. Gutierrez, Max Hardy Werbin +6 more

SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0606

N/A

0DataRank · unranked

11 citations

Megan Othus, Sandip Pravin Patel, Kelly J. Wilkinson, Emily M. Whitman-Purves, Jayanthi Lea +21 more

Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival

Journal of Cancer Research and Clinical Oncology(2022)10.1007/s00432-022-04340-3

N/A

0DataRank · unranked

40 citations

Gabriel Tinoco, Songzhu Zhao, Lai Wei, Andrew Johns, Sandip Pravin Patel +14 more

Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions

Cell(2022)10.1016/j.cell.2022.09.005

N/A

0DataRank · unranked

510 citations

Gregory D. Sepich‐Poore, Ilana Livyatan, Omer Asraf, Cameron Martino, Deborah Nejman +21 more

Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.14.436660

N/A

0DataRank · unranked

1 citations

Victoria H. Wu, Eva Pérez‐Guijarro, Hyo Kim, Andrea Castro, James V. Talwar +20 more

Challenges and opportunities for early phase clinical trials of novel drug–radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)

The Lancet Oncology(2024)10.1016/s1470-2045(24)00264-x

N/A

0DataRank · unranked

6 citations

Siddharth Sheth, Salma K. Jabbour, Krishnan R. Patel, Randall J. Kimple, Terence M. Williams +9 more

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1957

N/A

0DataRank · unranked

6 citations

Lucy Corthell, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Hye Sung Kim +10 more

Germline DNA damage response gene mutations as predictive biomarkers of immune checkpoint inhibitor efficacy

Frontiers in Immunology(2024)10.3389/fimmu.2024.1322187

N/A

0DataRank · unranked

3 citations

Sophia Bylsma, Lisa Madlensky, Meghana S. Pagadala, Hannah Carter, Sandip Pravin Patel +1 more

HIV Integration into the PTEN Gene and Its Tumor Microenvironment Implications for Lung Cancer

Current Oncology(2025)10.3390/curroncol32070389

N/A

0DataRank · unranked

4 citations

Elizabeth F. Rowland, Sara Gianella, Sandip Pravin Patel, Stephanie Solso, Cheryl Dullano +8 more

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Cancer Communications(2025)10.1002/cac2.70020

N/A

0DataRank · unranked

3 citations

Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z. Win, Tanya Pejovic +12 more

Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.02.025

N/A

0DataRank · unranked

70 citations

Mizuki Nishino, Sandip Pravin Patel, Bairavi Shankar, Natasha Rekhtman, Peter B. Illei +2 more

1469 A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic disease

(2022)10.1136/jitc-2022-sitc2022.1469

N/A

0DataRank · unranked

0 citations

Megan Othus, Young Kwang Chae, Michael J. Dennis, Sarah Gordon, David G. Mutch +7 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

10.1158/1078-0432.c.6530837.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5517

N/A

0DataRank · unranked

4 citations

Megan Othus, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Liam Il‐Young Chung +8 more

Data from A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

(2023)10.1158/1078-0432.c.6530837

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze +23 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16330

N/A

0DataRank · unranked

0 citations

Elizabeth Guadarrama, Young Kwang Chae, Chih‐Yi Liao, Anup Kasi, Grace R. Tarabay +12 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11516

N/A

0DataRank · unranked

0 citations

Megan Othus, Sandip Pravin Patel, Benjamin Powers, Chung-Tsen Hsueh, Rangaswamy Govindarajan +10 more

The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100427

N/A

0DataRank · unranked

12 citations

Shuai Chen, Joanna B. Eldredge, Shiruyeh Schokrpur, Debory Li, Zhikuan Quan +11 more

Improved survival in cervical cancer patients receiving care at National Cancer Institute–designated cancer centers

Cancer(2022)10.1002/cncr.34404

N/A

0DataRank · unranked

15 citations

Christine H. Feng, Marı́a Elena Martı́nez, Alison J. Canchola, Scarlett Lin Gomez, Jesse Nodora +4 more

Sandip Pravin Patel

Indexed papers

Top data-sharing exemplar

Papers